Index 
 Previous 
 Next 
 Full text 
Procedure : 2017/2576(RSP)
Document stages in plenary
Select a document :

Texts tabled :

O-000045/2017 (B8-0321/2017)

Debates :

PV 03/07/2017 - 20
CRE 03/07/2017 - 20

Votes :

Texts adopted :


Minutes
Monday, 3 July 2017 - StrasbourgFinal edition

20. HIV, TB and HCV epidemics in Europe on the rise (debate)
CRE

Question for oral answer (O-000045/2017) by Françoise Grossetête, Claudiu Ciprian Tănăsescu, Urszula Krupa, Frédérique Ries, Kateřina Konečná, Martin Häusling, Piernicola Pedicini and Mireille D'Ornano, on behalf of the ENVI Committee, to the Commission: HIV, TB and HCV epidemics in Europe on the rise (2017/2576(RSP))(B8-0321/2017)

Kateřina Konečná moved the question.

Vytenis Povilas Andriukaitis (Member of the Commission) answered the question.

IN THE CHAIR: Ildikó GÁLL-PELCZ
Vice-President

The following spoke: Françoise Grossetête, on behalf of the PPE Group, Claudiu Ciprian Tănăsescu, on behalf of the S&D Group, Urszula Krupa, on behalf of the ECR Group, Gesine Meissner, on behalf of the ALDE Group, Margrete Auken, Julia Reid, on behalf of the EFDD Group, Mireille D'Ornano, on behalf of the ENF Group, Karin Kadenbach, Notis Marias, Merja Kyllönen, Piernicola Pedicini, Lampros Fountoulis, Annie Schreijer-Pierik, who also replied to a blue-card question by Liisa Jaakonsaari, Christel Schaldemose, Ruža Tomašić, Nikolaos Chountis, Cristian-Silviu Buşoi, Daciana Octavia Sârbu, João Ferreira, Elżbieta Katarzyna Łukacijewska, Miriam Dalli and Paloma López Bermejo.

The following spoke under the catch-the-eye procedure: Seán Kelly, Nicola Caputo, Eleftherios Synadinos, Maria Grapini and Krisztina Morvai.

The following spoke: Vytenis Povilas Andriukaitis.

Motion for a resolution to wind up the debate tabled under Rule 128(5):

—   Françoise Grossetête, Claudiu Ciprian Tănăsescu, Urszula Krupa, Frédérique Ries, Kateřina Konečná, Martin Häusling, Piernicola Pedicini et Mireille D’Ornano, on behalf of the ENVI Committee, on the EU’s response to HIV/AIDS, Tuberculosis and Hepatitis C (2017/2576(RSP)) (B8-0436/2017).

The debate closed.

Vote: minutes of 5.7.2017, item 8.8.

Legal notice